Grete Fjelstad

Grete Fjelstad has a diverse work experience in the biotechnology and diagnostic market. Grete currently works as an Associate Director CMC Compliance at Nykode Therapeutics, a role they have held since April 2023. Prior to that, they founded and served as CEO of BIOSUPPORT from December 2013. At BIOSUPPORT, Grete provided assistance to companies in need of limited resources in the biotechnology and diagnostic field.

In 2014, Grete joined XOventure as a Director where they helped build and support life science companies globally. Grete continued in this role until December 2018. In 2015, they briefly worked at Ophiuchus Technologies AG as the VP of Production and Customer Service, focusing on delivering clinical breakthroughs in Spinal Cord Injury using stem cell technology.

Grete's earlier experience includes multiple roles at Diatec Monoclonals, where they served as a Sales Director, Managing Director, Sales Manager, Business Development Manager, and Laboratory engineer. Grete was responsible for sales management, business development, and technical management during their time at the company. Grete started their career as a Bioingeniør at IGRI Rikshospitalet from 1995 to 1997.

Overall, Grete Fjelstad has over 25 years of work experience in various roles in the biotechnology industry, with expertise in research, sales, management, and business development.

Grete Fjelstad attended Sør-Trøndelag University College (HiST) from 1992 to 1995. No specific degree or field of study information is available.